Clostridium butyricum and Clostridium tyrobutyricum: angel or devil for necrotizing enterocolitis?
mSystems
; 8(6): e0073223, 2023 Dec 21.
Article
in En
| MEDLINE
| ID: mdl-37921463
IMPORTANCE: This study sheds light on that treatment with Clostridium tyrobutyricum but not Clostridium butyricum is entitled to protect against necrotizing enterocolitis (NEC) development potentially. The mechanisms behind the opposite effect on NEC may result in different modulation on the level of Akkermansia muciniphila, which is deeply associated with intestinal homoeostasis. Briefly, through improving the abundance of A. muciniphila to alleviate intestinal inflammation and enhance intestinal barrier integrity, C. tyrobutyricum supplement may become a promising therapy for NEC.
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Probiotics
/
Enterocolitis, Necrotizing
/
Clostridium butyricum
/
Clostridium tyrobutyricum
/
Fetal Diseases
/
Infant, Newborn, Diseases
Limits:
Female
/
Humans
/
Newborn
Language:
En
Year:
2023
Type:
Article